iHCK-37 is primarily utilized in biochemical research as a potent and selective inhibitor targeting specific kinase pathways. It is particularly valuable in studies focused on understanding cellular signaling mechanisms, especially those involving immune responses and cancer biology. Researchers use iHCK-37 to modulate kinase activity, enabling the exploration of its role in disease progression and potential therapeutic interventions. Its application extends to drug discovery, where it aids in identifying and validating new targets for treating conditions like inflammatory disorders and malignancies. Additionally, iHCK-37 is employed in preclinical models to assess its efficacy and safety profile, contributing to the development of novel kinase-targeted therapies.